Clinical Trial Update: Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluated alpha-1 antitrypsin therapy in patients with acute myocardial infarction in Phase 1 and Phase 2. The study is completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Alpha-1 Antitrypsin (alpha-1 antitrypsin)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Acute Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-02-12